Lessee, Operating Lease, Liability, to be Paid of ABVC BIOPHARMA, INC. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary: ABVC BIOPHARMA, INC. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
ABVC BIOPHARMA, INC. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $378,460, a 26% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$378,460	-$130,473	-26%	30 Sep 2025	10-Q	03 Nov 2025	2025	Q3
Q2 2025	$472,846	-$136,056	-22%	30 Jun 2025	10-Q	13 Aug 2025	2025	Q2
Q1 2025	$547,017	-$163,716	-23%	31 Mar 2025	10-Q	30 Apr 2025	2025	Q1
Q4 2024	$655,782	-$157,231	-19%	31 Dec 2024	10-K	15 Apr 2025	2024	FY
Q3 2024	$508,933	-$395,693	-44%	30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q2 2024	$608,902	-$396,923	-39%	30 Jun 2024	10-Q	14 Aug 2024	2024	Q2
Q1 2024	$710,733			31 Mar 2024	10-Q	17 May 2024	2024	Q1
Q4 2023	$813,013			31 Dec 2023	10-K	13 Mar 2024	2023	FY
Q3 2023	$904,626			30 Sep 2023	10-Q	15 Nov 2023	2023	Q3
Q2 2023	$1,005,825			30 Jun 2023	10-Q	14 Aug 2023	2023	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.